Bill Text: CA SJR7 | 2009-2010 | Regular Session | Chaptered
Bill Title: Pancreatic cancer.
Spectrum: Slight Partisan Bill (Democrat 44-20)
Status: (Passed) 2009-08-24 - Chaptered by Secretary of State. Res. Chapter 85, Statutes of 2009. [SJR7 Detail]
Download: California-2009-SJR7-Chaptered.html
BILL NUMBER: SJR 7 CHAPTERED BILL TEXT RESOLUTION CHAPTER 85 FILED WITH SECRETARY OF STATE AUGUST 24, 2009 ADOPTED IN SENATE AUGUST 17, 2009 ADOPTED IN ASSEMBLY JULY 9, 2009 AMENDED IN ASSEMBLY JULY 9, 2009 INTRODUCED BY Senator Lowenthal (Principal coauthor: Assembly Member Torlakson) (Coauthors: Senators Ashburn and Maldonado) (Coauthors: Assembly Members Ma, Ammiano, Arambula, Beall, Bass, Bill Berryhill, Tom Berryhill, Blakeslee, Block, Blumenfield, Brownley, Buchanan, Caballero, Carter, Chesbro, Cook, Coto, Davis, DeVore, Emmerson, Eng, Evans, Feuer, Fletcher, Fong, Fuentes, Furutani, Gaines, Galgiani, Garrick, Gilmore, Hagman, Harkey, Hayashi, Hill, Huber, Huffman, Jeffries, Jones, Lieu, Logue, Mendoza, Miller, Monning, Nava, Nestande, John A. Perez, V. Manuel Perez, Portantino, Ruskin, Salas, Saldana, Skinner, Solorio, Audra Strickland, Swanson, Torres, Torrico, Tran, and Yamada) APRIL 20, 2009 Relative to pancreatic cancer. LEGISLATIVE COUNSEL'S DIGEST SJR 7, Lowenthal. Pancreatic cancer. This measure would urge the President and the Congress of the United States to expand federally funded research efforts aimed at developing a reliable means of detecting pancreatic cancer in its early stages. WHEREAS, Approximately 38,000 Americans, including an estimated 3,625 Californians, will be diagnosed with pancreatic cancer this year; and WHEREAS, Seventy-five percent of pancreatic cancer patients die within the first year of their diagnosis, and 95 percent die within five years, making pancreatic cancer the deadliest of any cancer; and WHEREAS, Pancreatic cancer is the fourth most common cause of cancer death in the United States, with an estimated 3,380 Californians expected to die from pancreatic cancer in 2009; and WHEREAS, There has been no significant improvement in pancreatic cancer survival rates in over 30 years, and pancreatic cancer research is still in the earliest scientific stages; and WHEREAS, There are no early detection methods and minimal treatment options for pancreatic cancer; and WHEREAS, The incidence rate of pancreatic cancer is 40 to 50 percent higher in African Americans than in other ethnic groups, with Jews of Ashkenazi descent also at an increased genetic risk; and WHEREAS, Pancreatic cancer has struck such notable figures as Justice Ruth Bader Ginsberg, Patrick Swayze, Dr. Randy Pausch, and Luciano Pavarotti; and WHEREAS, Pancreatic cancer research constitutes less than 2 percent of the National Cancer Institute's federal research funding, a figure far too low given the severity of the disease, its mortality rate, and how little is known about how to arrest it; and WHEREAS, There is a critical need to support research that identifies new methods of detecting and treating pancreatic cancer; and WHEREAS, H.R. 745 was introduced in the United States House of Representatives by California Congresswoman Anna Eshoo to require the establishment of a Pancreatic Cancer Initiative and an Interdisciplinary Pancreatic Cancer Coordinating Committee to, among other things, provide advice on overall research objectives and benchmarks for pancreatic cancer research; now, therefore, be it Resolved by the Senate and the Assembly of the State of California, jointly, That the Legislature of the State of California urges the President and Congress of the United States to expand federally funded research efforts aimed at developing a reliable means of detecting pancreatic cancer in its early stages and more effective means of treatment, through legislative measures, such as H.R. 745; and be it further Resolved, That the Secretary of the Senate transmit copies of this resolution to the President and Vice President of the United States, to the Speaker of the House of Representatives, to each Senator and Representative from California in the Congress of the United States, and to the directors of the National Institutes of Health and the National Cancer Institute.